-
-
-
[1] Malthews MJ.The pathology of non-small cell carcinoma of the lung[J].Semin Oncol,1983, 10(1): 34. [2] Guo NN,Li J,Zhang W.Small cell lung carcinoma with adenocarcinoma,bronchiolo-alveolar: a case report[J].Lin Chuang Jun Yi Za Zhi,2008,36(5):679.[郭楠楠，李捷，张文.肺小细 胞癌肺癌合并腺癌、细支气管肺泡癌1例[J].临床军医杂 志,2008,36(5):679.] [3] Takada M,Fukuoka M,Kawahara M,et al.Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 91 04[J].J Clin Oncol,2002,20(14):3054-60. [4] Felix CA,Hosler MR, Winick NJ,et al.ALL-1 gene rearrangements in DNA topoisoneraseⅡinhibitor-related leukemia in children[J]. Blood,1995,85(11):3250. [5] Krishnan A,Bhatia S,Slovak ML,et al.Predictors of therapyrelated leukemia and myelodysplasia following autologous transplantation for lymphoma an assessment of risk factors[J]. Blood,2000, 95(5):1588-93. [6] Kollmannsberger C,Beyer J,Droz JP,et al.Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors[J].J Clin Oncol,1998,16(10):3386- 91. [7] Houck W,Abonour R,Vance G,et al.Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide[J].J Clin Oncol,2004,22:2155-8.
下载:
